首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Microdialysis as a tool to determine free kidney levels of voriconazole in rodents: a model to study the technique feasibility for a moderately lipophilic drug.
【24h】

Microdialysis as a tool to determine free kidney levels of voriconazole in rodents: a model to study the technique feasibility for a moderately lipophilic drug.

机译:微透析作为确定啮齿动物中伏立康唑游离肾脏水平的工具:研究中度亲脂药物技术可行性的模型。

获取原文
获取原文并翻译 | 示例
           

摘要

Microdialysis has been employed for the in vivo measurement of endogenous compounds and a variety of drugs in different tissues. The applicability of this technique can be limited by drug lipophilicity which can impair the diffusion through dialysis membrane. The objective of this study was to evaluate the feasibility of using microdialysis to study kidney penetration of voriconazole, a moderately lipophilic antifungal triazolic agent (LogD7.4=1.8). Microdialysis probe recoveries were investigated in vitro by dialysis and retrodialysis using four different drug concentrations (0.1-2 microg/mL) at five flow rates (1-5 microL/min). Recoveries were dependent on the method used for the determination as well as on the flow rate, but independent of drug concentration. The average apparent recoveries determined by dialysis and retrodialysis, at flow rate of 2 microL/min, were 21.1+/-1.5% and 28.7+/-2.0%, respectively. Recovery by retrodialysis was bigger than the recovery by dialysis. The average apparent dialysis/retrodialysis recovery ratio in vitro was 0.73 for all concentrations investigated. The differences between retrodialysis and dialysis recoveries were attributed to the drug's binding to the plastic tubing before and after the dialysis membrane which was experimentally evaluated and mathematically modeled. The in vivo apparent recovery determined by retrodialysis in healthy Wistar rats' kidney was 38.5+/-3.5%, similar to that observed in vitro using the same method (28.7+/-2.0%). The in vivo apparent recovery after correcting for plastic tubing binding (25.1+/-2.8%) was successfully used for determining free kidney levels of voriconazole in rats following 40 and 60mg/kg oral dosing. The results confirmed that microdialysis can be used as sampling technique to determine free tissue levels of moderately lipophilic drugs once the contribution of tubing binding and membrane diffusion on the apparent recovery are disentangled.
机译:微透析已用于体内测量不同组织中的内源性化合物和多种药物。该技术的适用性可能受到药物亲脂性的限制,该亲脂性会损害通过透析膜的扩散。这项研究的目的是评估使用微透析研究伏立康唑(一种中等亲脂性抗真菌三唑类药物(LogD7.4 = 1.8))对肾脏渗透的可行性。通过在五个流速(1-5 microL / min)下使用四种不同药物浓度(0.1-2 microg / mL)进行透析和逆透析,体外研究了微透析探针的回收率。回收率取决于用于测定的方法以及流速,但与药物浓度无关。通过透析和逆透析确定的平均表观回收率分别为2 microL / min,分别为21.1 +/- 1.5%和28.7 +/- 2.0%。通过逆透析的恢复大于通过透析的恢复。对于所研究的所有浓度,体外平均表观透析/再透析恢复率均为0.73。透析后和透析回收率之间的差异归因于药物在透析膜之前和之后与塑料管的结合,这是通过实验评估和数学建模的。在健康的Wistar大鼠肾脏中,通过逆透析确定的体内表观恢复率为38.5 +/- 3.5%,类似于使用相同方法在体外观察到的表观恢复(28.7 +/- 2.0%)。校正塑料管结合后(25.1 +/- 2.8%)的体内表观恢复率已成功用于确定40和60mg / kg口服给药后大鼠伏立康唑的游离肾脏水平。结果证实,一旦管结合和膜扩散对表观恢复的贡献被解开,微透析可以用作确定中度亲脂性药物自由组织水平的采样技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号